VICA (Rafina Innovations) Marketable Securities: $0.00 Mil (As of Mar. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VICA Rafina Innovations Inc VICA
12 GF Score
Price $0.00
View Full Analysis

What is Rafina Innovations Marketable Securities?

Rafina Innovations VICA 12 Marketable Securities is $0.00 Mil as of Mar. 2019. GuruFocus rates VICA with a GF Score™ of 12/100.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Rafina Innovations's Marketable Securities for the quarter that ended in Mar. 2019 was $0.00 Mil.

Rafina Innovations  (OTCPK:VICA) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Rafina Innovations Marketable Securities Related Terms

Rafina Innovations Marketable Securities Historical Data

* Premium members only.

The historical data trend for Rafina Innovations's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rafina Innovations Marketable Securities Chart

Rafina Innovations Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Rafina Innovations Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
VICA
12GF Score
Rafina Innovations Inc VICA
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rafina Innovations Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
Rafina Innovations (VICA) has a Marketable Securities of $0.00 Mil as of Mar. 2019. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Rafina Innovations and its competitors.
Is Rafina Innovations' Marketable Securities too high?
Rafina Innovations' current Marketable Securities is $0.00 Mil. Overall, Rafina Innovations has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Rafina Innovations' Marketable Securities compare to RMSL and GTHP?
Rafina Innovations' Marketable Securities of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Rafina Innovations and its competitors. Rafina Innovations's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rafina Innovations stock overvalued right now?
Rafina Innovations (VICA) has a current Marketable Securities of $0.00 Mil. The current Marketable Securities is $0.00 Mil. Rafina Innovations' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Rafina Innovations (VICA), the current Marketable Securities is $0.00 Mil as of Mar. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rafina Innovations Business Description

Address 123 West Nye Lane, Suite 129, Carson City, NV, USA, 89706
Rafina Innovations Inc through its subsidiaries is involved in the development of monitoring technologies, set up of rehabilitation centers, development of intellectual property related to everyday fields such as healthcare, sports, automotive and gaming as well as the creation of full-service Prosthetics and Orthotics and Diabetic foot clinics chain in Europe and the Middle East. The firm's main products include Flexisense technology and Rehabilitation clinics etc. It has Clinics and Technology operating segments and derives a majority of its revenues from Clinics segment.
12GF Score

Get the complete analysis for VICA

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price